MD 85

• Description :

  MD 85 is a potent histone deacetylase (HDAC) inhibitor with an EC50 of 5 μM. MD 85 can be used for cancer research[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H312-H332

• Target :

  HDAC

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Epigenetics

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/md-85.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NCCCCCC(NO)=O)C1=CC=C(N(C)C)C=C1

• Molecular Formula :

  C15H23N3O3

• Molecular Weight :

  293.36

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations :

  [1]Klan N, et al. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity. Biol Chem. 2003 May;384 (5) :777-85.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [193551-00-7]